Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
Authors
Keywords
Algorithm, Bone, Bone biomarker, CTX, Osteoporosis, P1NP, Rheumatology
Journal
ADVANCES IN THERAPY
Volume 36, Issue 10, Pages 2811-2824
Publisher
Springer Science and Business Media LLC
Online
2019-08-23
DOI
10.1007/s12325-019-01063-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treating osteoporosis to prevent fractures: current concepts and future developments
- (2019) Mattias Lorentzon JOURNAL OF INTERNAL MEDICINE
- Reference markers of bone turnover for prediction of fracture: a meta-analysis
- (2019) Aixian Tian et al. Journal of Orthopaedic Surgery and Research
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates
- (2017) B. Uebelhart et al. OSTEOPOROSIS INTERNATIONAL
- International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
- (2017) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
- (2017) P. Szulc et al. OSTEOPOROSIS INTERNATIONAL
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Use of bone turnover markers in postmenopausal osteoporosis
- (2017) Richard Eastell et al. Lancet Diabetes & Endocrinology
- UK clinical guideline for the prevention and treatment of osteoporosis
- (2017) J. Compston et al. Archives of Osteoporosis
- Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study
- (2016) David W. Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study
- (2016) E. A. Marques et al. OSTEOPOROSIS INTERNATIONAL
- A systematic review of intervention thresholds based on FRAX
- (2016) John A. Kanis et al. Archives of Osteoporosis
- Osteoporosis: the evolution of a diagnosis
- (2015) M. Lorentzon et al. JOURNAL OF INTERNAL MEDICINE
- Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
- (2015) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture
- (2014) Helena Johansson et al. CALCIFIED TISSUE INTERNATIONAL
- Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups
- (2014) Jane Burch et al. HEALTH TECHNOLOGY ASSESSMENT
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Goal-directed treatment of osteoporosis in Europe
- (2014) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Changes in Bone Resorption Across the Menopause Transition: Effects of Reproductive Hormones, Body Size, and Ethnicity
- (2013) MaryFran R. Sowers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis
- (2011) Samuel Vasikaran et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis
- (2011) Emmanuel Biver et al. JOINT BONE SPINE
- Official Positions for FRAX® Clinical Regarding Biochemical Markers
- (2011) Eugene V. McCloskey et al. JOURNAL OF CLINICAL DENSITOMETRY
- Mineral Metabolism Markers and the Long-Term Risk of Hip Fracture: The Cardiovascular Health Study
- (2011) Cassianne Robinson-Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone-turnover markers in fracture healing
- (2010) G. Cox et al. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
- Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
- (2010) Patrick Garnero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
- (2010) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
- (2009) Sarah J. Glover et al. BONE
- Bone turnover markers and prediction of fracture: A prospective follow-up study of 1040 elderly women for a mean of 9 years
- (2009) Kaisa K Ivaska et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club
- (2008) P. Bergmann et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Serial Assessment of Serum Bone Metabolism Markers Identifies Women with the Highest Rate of Bone Loss and Osteoporosis Risk
- (2008) Kaisa K. Ivaska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis
- (2008) P. Szulc et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- A reference standard for the description of osteoporosis
- (2007) John A. Kanis et al. BONE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started